查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1465569

脊椎骨刺激器市场- 按设备类型{侵入式、非侵入式[脉衝电磁场设备、电容耦合(CC) 设备、组合（电）磁场(CMF) 设备]}、最终用途（医院、ASC） -全球2024 - 2032 年预测

Spine Bone Stimulators Market - By Device Type {Invasive, Non-Invasive [Pulsed Electromagnetic Field Devices, Capacitive Coupling (CC) Devices, Combined (Electro) Magnetic Field (CMF) Devices]}, End-use (Hospitals, ASCs) - Global Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3个工作天内

价格
简介目录

由于领先公司的批准和专利不断增加，2024 年至 2032 年间，全球脊椎骨刺激器市场的复合年增长率将超过 5.7%。由于脊椎疾病持续困扰着大部分人群，创新的解决方案对于有效治疗至关重要。

例如，2022 年 8 月，医疗器材公司 Theragen 很高兴地宣布授予一项美国专利，认可其在创建 ActaStim-S 脊椎融合骨生长刺激器系统方面的创新策略。 ActaStim-S 是数十年来首款新型脊椎融合刺激器，将经过临床验证的治疗刺激与现代设计元素和富含资料的综合数位健康平台相结合。

领先公司正大力投资研发，将新型骨刺激技术推向市场。这些进步提高了患者的治疗效果，同时解决了脊椎护理中未满足的医疗需求。随着监管部门的批准和专利推动市场竞争力，公司准备推出各种骨骼刺激器，以满足不同患者的需求。创新的激增凸显了研发在塑造脊椎骨刺激器市场未来的关键作用。

整个脊椎骨刺激器产业根据设备类型、最终用途和地区进行分类。

侵入性脊椎骨刺激器领域将在 2024 年至 2032 年间实现显着增长。当患者寻求退化性椎间盘疾病和脊椎骨折等脊椎疾病的解决方案时，侵入性脊椎骨刺激器提供了一种有前途的治疗选择。它们加速癒合和改善脊椎稳定性的能力使其在医疗保健提供者和患者中广受欢迎，从而刺激了脊椎骨刺激器市场的需求。

从 2024 年到 2032 年，专科诊所领域的脊椎骨刺激器市场份额将实现显着的复合年增长率。当患者寻求适合其特定需求的综合治疗方案时，专科诊所提供治疗脊椎疾病的专业知识和个人化护理。他们对创新疗法和以患者为中心的方法的重视导致对脊椎骨刺激器的需求增加，反映出专业医疗服务在解决脊椎相关问题方面日益重要。

欧洲脊椎骨刺激器市场从 2024 年到 2032 年将呈现出值得称讚的复合年增长率。欧洲医疗保健系统优先考虑使用先进的医疗技术，包括脊椎骨刺激器，以改善患者的治疗结果。此外，该地区对研究和开发的重视促进了新型骨刺激疗法的引入，进一步推动了市场成长。随着患者和医疗保健提供者寻求脊椎疾病的有效解决方案，欧洲对脊椎骨刺激器的需求持续增长，塑造了脊椎护理的模式。

例如，2022年2月，洛桑大学医院的Jocelyne Bloch博士和瑞士联邦理工学院的Gregoire Courtine进行的一项脊髓刺激研究取得了突破性结果。週一发表在《自然医学》杂誌上的 STIMO 临床试验重新利用了最初旨在缓解疼痛的现有技术，专门针对脊神经根，改进了脊椎刺激方法。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 脊柱畸形发生率上升
      • 微创手术的需求不断增加
      • 设备技术进步
    • 产业陷阱与挑战
      • 设备成本高且报销率低
  • 成长潜力分析
  • 监管环境
  • 技术景观
  • 报销场景
  • 波特的分析
  • PESTEL分析
  • 未来市场趋势

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按设备类型，2018 年 - 2032 年

  • 主要趋势
  • 侵入式脊椎骨刺激器
  • 非侵入性脊椎骨刺激器
    • 脉衝电磁场装置
    • 电容耦合 (CC) 装置
    • 组合（电）磁场 (CMF) 设备

第 6 章：市场估计与预测：依最终用途，2018 - 2032 年

  • 主要趋势
  • 医院
  • 专科诊所
  • 门诊手术中心
  • 其他最终用户

第 7 章：市场估计与预测：按地区划分，2018 年 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋
    • 中东和非洲其他地区

第 8 章：公司简介

  • Bioventus
  • Elizur Corporation
  • Enovis (DJO Global, Inc.)
  • IGEA S.p.A.
  • Medtronic plc
  • Orthofix Medical Inc.
  • Ossatec Benelux BV
  • Synergy Orthopedics
  • Theragen, Inc. (Neurotech NA Inc.)
  • ZimVie Inc
简介目录
Product Code: 8314

Global Spine Bone Stimulators Market will witness over 5.7% CAGR between 2024 and 2032 due to increasing approvals and patents from leading companies. As spinal conditions continue to afflict a large segment of the population, innovative solutions are imperative for effective treatment.

For instance, in August 2022, Theragen, a medical device company, was delighted to announce the granting of a U.S. Patent recognizing its inventive strategy in creating the ActaStim-S Spine Fusion Bone Growth Stimulator system. Representing the first new Spine Fusion Stimulator in decades, ActaStim-S combined clinically validated therapeutic stimulation with contemporary design elements and a comprehensive digital health platform enriched with data.

Leading firms are investing extensively in research and development to bring novel bone stimulation technologies to market. These advancements enhance patient outcomes while addressing unmet medical needs in spine care. With regulatory approvals and patents driving market competitiveness, companies are poised to introduce a wide array of bone stimulators catering to diverse patient requirements. This surge in innovation underscores the pivotal role of research and development in shaping the future of the Spine Bone Stimulators Market.

The overall Spine Bone Stimulators Industry is classified based on the device type, end-use, and region.

The invasive spine bone stimulators segment will record significant growth from 2024 to 2032. These advanced medical devices are designed to stimulate bone growth and promote fusion in the spine through surgical implantation. As patients seek solutions for spinal conditions such as degenerative disc disease and spinal fractures, invasive spine bone stimulators offer a promising treatment option. Their ability to accelerate healing and improve spinal stability drives their popularity among healthcare providers and patients alike, fueling demand in the Spine Bone Stimulators Market.

Spine bone stimulators market share from the specialty clinics segment will register a noteworthy CAGR from 2024 to 2032. These clinics focus on providing specialized care for spinal conditions, including the use of bone stimulators to promote healing and fusion. As patients seek comprehensive treatment options tailored to their specific needs, specialty clinics offer expertise and personalized care in managing spinal disorders. Their emphasis on innovative therapies and patient-centric approaches contributes to the increased demand for spine bone stimulators, reflecting the growing importance of specialized healthcare services in addressing spine-related issues.

Europe spine bone stimulators market will showcase a commendable CAGR from 2024 to 2032. With a growing aging population and increasing prevalence of spinal disorders, there is a heightened demand for innovative treatment options. European healthcare systems prioritize access to advanced medical technologies, including spine bone stimulators, to improve patient outcomes. Additionally, the region's emphasis on research and development fosters the introduction of novel bone stimulation therapies, further driving market growth. As patients and healthcare providers seek effective solutions for spinal conditions, the demand for spine bone stimulators in Europe continues to rise, shaping the landscape of spine care.

For instance, in February 2022, A spinal cord stimulation study conducted by Dr. Jocelyne Bloch of Lausanne University Hospital and Gregoire Courtine of the Swiss Federal Institute of Technology yielded groundbreaking results. Published in the journal Nature Medicine on Monday, the STIMO clinical trial repurposed existing technology, originally aimed at pain relief, to specifically target spinal nerve roots, improving spine stimulation methods.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rise in incidence of spinal deformities
      • 3.2.1.2 Increasing demand for minimally invasive procedures
      • 3.2.1.3 Technological advancements in devices
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High device cost and lack of reimbursement rates
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Reimbursement scenario
  • 3.7 Porter's analysis
    • 3.7.1 Supplier power
    • 3.7.2 Buyer power
    • 3.7.3 Threat of new entrants
    • 3.7.4 Threat of substitutes
    • 3.7.5 Industry rivalry
  • 3.8 PESTEL analysis
  • 3.9 Future market trends

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Device Type, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Invasive spine bone stimulators
  • 5.3 Non-invasive spine bone stimulators
    • 5.3.1 Pulsed electromagnetic field devices
    • 5.3.2 Capacitive coupling (CC) devices
    • 5.3.3 Combined (electro) magnetic field (CMF) devices

Chapter 6 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Hospitals
  • 6.3 Specialty clinics
  • 6.4 Ambulatory surgical centers
  • 6.5 Other end-users

Chapter 7 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
    • 7.4.6 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 Middle East and Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 South Africa
    • 7.6.3 UAE
    • 7.6.4 Rest of Middle East and Africa

Chapter 8 Company Profiles

  • 8.1 Bioventus
  • 8.2 Elizur Corporation
  • 8.3 Enovis (DJO Global, Inc.)
  • 8.4 IGEA S.p.A.
  • 8.5 Medtronic plc
  • 8.6 Orthofix Medical Inc.
  • 8.7 Ossatec Benelux BV
  • 8.8 Synergy Orthopedics
  • 8.9 Theragen, Inc. (Neurotech NA Inc.)
  • 8.10 ZimVie Inc